Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 20

Results For "C"

10617 News Found

Prof. Gobardhan Das appointed to NITI Aayog; PM Modi commends his contributions to R&D
People | April 27, 2026

Prof. Gobardhan Das appointed to NITI Aayog; PM Modi commends his contributions to R&D

His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research


Wellness travel is moving closer to home: What’s driving the shift?
Opinion | April 27, 2026

Wellness travel is moving closer to home: What’s driving the shift?

India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle


Sun Pharma to acquire Organon in $11.75 billion all-cash deal
News | April 27, 2026

Sun Pharma to acquire Organon in $11.75 billion all-cash deal

Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally


Alembic announces FDA final approval for Fingolimod capsules
Drug Approval | April 27, 2026

Alembic announces FDA final approval for Fingolimod capsules

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Gilenya Capsules, 0.5 mg of Novartis Pharmaceuticals Corporation (Novartis)


Nihilent unveils nSEPIA Beta to turn emotional wellness into measurable science
News | April 27, 2026

Nihilent unveils nSEPIA Beta to turn emotional wellness into measurable science

nSEPIA aims to bring structure to an area long dominated by subjectivity


BMS–Pfizer expands Eliquis access through Cost Plus Drug setting $345 monthly price
Supply Chain | April 27, 2026

BMS–Pfizer expands Eliquis access through Cost Plus Drug setting $345 monthly price

The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform


Zydus wins DCGI nod to launch Phase III trials of new anti-malarial drug Zintrodiazine
Clinical Trials | April 27, 2026

Zydus wins DCGI nod to launch Phase III trials of new anti-malarial drug Zintrodiazine

The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine


Cipla wins USFDA nod for first generic of Ventolin HFA strengthening respiratory push
Drug Approval | April 27, 2026

Cipla wins USFDA nod for first generic of Ventolin HFA strengthening respiratory push

The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA


Huwel Lifesciences, ASMS expand into Southeast Asia with Singapore partner
Supply Chain | April 27, 2026

Huwel Lifesciences, ASMS expand into Southeast Asia with Singapore partner

Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform


Maarga Mind Care launches integrative day care program to bridge mental health recovery gap
Healthcare | April 27, 2026

Maarga Mind Care launches integrative day care program to bridge mental health recovery gap

New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery